These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25899872)

  • 1. Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy.
    Bentzley BS; Barth KS; Back SE; Aronson G; Book SW
    J Subst Abuse Treat; 2015 Sep; 56():48-53. PubMed ID: 25899872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes.
    Bentzley BS; Barth KS; Back SE; Book SW
    J Subst Abuse Treat; 2015 May; 52():48-57. PubMed ID: 25601365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
    Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
    Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The real-world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine.
    Farnum SO; Makarenko I; Madden L; Mazhnaya A; Marcus R; Prokhorova T; Bojko MJ; Rozanova J; Dvoriak S; Islam Z; Altice FL
    Addiction; 2021 Jan; 116(1):83-93. PubMed ID: 32428276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.
    DeFlavio JR; Rolin SA; Nordstrom BR; Kazal LA
    Rural Remote Health; 2015; 15():3019. PubMed ID: 25651434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
    Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
    Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Testosterone and Sexual Function in Southeast Asian Men Receiving Methadone and Buprenorphine Maintenance Treatment.
    Yee A; Loh HS; Danaee M; Riahi S; Ng CG; Sulaiman AH
    J Sex Med; 2018 Feb; 15(2):159-166. PubMed ID: 29275046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of opioid maintenance treatments when analgesic treatments are required].
    Laprevote V; Geoffroy PA; Rolland B; Leheup BF; Di Patrizio P; Cottencin O; Schwan R
    Presse Med; 2013; 42(7-8):1085-90. PubMed ID: 23518339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worries About Discontinuing Buprenorphine Treatment: Scale Development and Clinical Correlates.
    Stein MD; Conti MT; Herman DS; Anderson BJ; Bailey GL; Noppen DV; Abrantes AM
    Am J Addict; 2019 Jul; 28(4):270-276. PubMed ID: 30993833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of interest in extended-released buprenorphine: A survey among 366 French patients treated with buprenorphine or methadone.
    Rolland B; Trojak B; Nourredine M; Bachellier J; Chappuy M; Bendimerad P; Kosim M; Hjelmström P; Meroueh F; Nubukpo P; Brousse G
    Drug Alcohol Depend; 2021 Mar; 220():108492. PubMed ID: 33482572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Too little dose - too early discontinuation?'-Effect of buprenorphine dose on short term treatment adherence in opioid dependence.
    Muruganandam P; Shukla L; Sharma P; Kandasamy A; Chand P; Murthy P
    Asian J Psychiatr; 2019 Aug; 44():58-60. PubMed ID: 31325758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harm Reduction Agencies as a Potential Site for Buprenorphine Treatment.
    Fox AD; Chamberlain A; Frost T; Cunningham CO
    Subst Abus; 2015; 36(2):155-60. PubMed ID: 25837290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial.
    Fiellin DA; Schottenfeld RS; Cutter CJ; Moore BA; Barry DT; O'Connor PG
    JAMA Intern Med; 2014 Dec; 174(12):1947-54. PubMed ID: 25330017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Smoking Cessation Methods Among Patients Receiving Office-based Buprenorphine Maintenance Treatment.
    Shah PA; Cunningham CO; Brisbane MT; DeLuca JP; Nahvi S
    J Addict Med; 2017; 11(6):494-497. PubMed ID: 28885300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous Misuse of Methadone, Buprenorphine and Buprenorphine-Naloxone in Patients Under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study.
    Lugoboni F; Zamboni L; Cibin M; Tamburin S;
    Eur Addict Res; 2019; 25(1):10-19. PubMed ID: 30625491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine Treatment and 12-step Meeting Attendance: Conflicts, Compatibilities, and Patient Outcomes.
    Monico LB; Gryczynski J; Mitchell SG; Schwartz RP; O'Grady KE; Jaffe JH
    J Subst Abuse Treat; 2015 Oct; 57():89-95. PubMed ID: 25986647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication-assisted treatment with buprenorphine: assessing the evidence.
    Thomas CP; Fullerton CA; Kim M; Montejano L; Lyman DR; Dougherty RH; Daniels AS; Ghose SS; Delphin-Rittmon ME
    Psychiatr Serv; 2014 Feb; 65(2):158-70. PubMed ID: 24247147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked variability in peri-partum anesthetic management of patients on buprenorphine maintenance therapy (BMT): can there be an underlying acute opioid induced hyperalgesia precipitated by neuraxial opioids in BMT patients?
    Gupta D; Christensen C; Soskin V
    Middle East J Anaesthesiol; 2013 Oct; 22(3):273-81. PubMed ID: 24649783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are patients' pejorative representations of buprenorphine associated with their level of addiction and of misuse?
    Vanderkam P; Gagey S; Ingrand P; Perault-Pochat MC; Brabant Y; Blanchard C; Tudrej B; Messaadi N; Binder P
    Drug Alcohol Depend; 2018 Jul; 188():10-15. PubMed ID: 29727755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014.
    Guan Q; Khuu W; Spithoff S; Kiran T; Kahan M; Tadrous M; Martins D; Leece P; Gomes T
    Drug Alcohol Depend; 2017 Aug; 177():315-321. PubMed ID: 28733101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.